Affinor Resources Inc.

Affinor Resources Inc.

April 24, 2014 08:00 ET

Affinor Appoints High Profile Sports Optometrist Dr. Alan R. Boyco to its Board of Directors

MONTREAL, QUEBEC--(Marketwired - April 24, 2014) - Affinor Resources Inc. (the "Company") (CSE:AFI)(FRANKFURT:1AF)(PINKSHEETS:RSSFF) is pleased to announce the appointment of Dr. Alan R. Boyco to its Board of Directors and Advisory Board.

Sebastien Plouffe, President & CEO, comments:"I'm extremely honoured that Dr. Boyco has agreed to join our Board of Directors. Besides his vast knowledge in CBD testing for glaucoma and business experience... he brings contacts and credibility in our medical field that will definitely assist the Company to achieve its goals. I can certainly say that I'm thrilled, and look forward to listening to his advice."

Alan R. Boyco, B.Sc., O.D. is a licensed Optometrist with expertise focused on sports eye care and anterior segment / glaucoma. He received his Bachelor of Science (Biology & Psychology) from the University of Alberta, and then went on to graduate from the Pacific University School of Optometry. He maintains multiple practices throughout the Lower Mainland of British Columbia.

Dr. Boyco enjoys the position of official Team Optometrist and Eye Care Provider to the various local Vancouver professional sports franchises covering the gamut from hockey to soccer. He is a member of the NHL TPS or "National Hockey League Team Physicians Society". His expertise has given him the opportunity to appear on morning television in a segment called "Eyes on Vancouver".

The Company has granted to Dr. Boyco one hundred thousand incentive stock options to purchase common shares. The options are exercisable on or before April 24, 2019 at an exercise price of $0.25 per share.

About Affinor Resources Inc.

Affinor Resources is a diversified publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on the Medical Marijuana industry within North America as well as Affinor has a Mineral Exploration division. Affinor is currently working towards becoming a premier Canadian Medical Marijuana and Industrial Hemp company by consolidating fragmented medical marijuana grower facilities and bringing industry expertise to its advisory board.

On Behalf of the Board of Directors


Sebastien Plouffe, President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact Information